Literature DB >> 17786470

Expression and distribution of MUC18 in human uveal melanoma.

Kenneth Lai1, Vidushi Sharma, Martine J Jager, R Max Conway, Michele C Madigan.   

Abstract

The immunoglobulin superfamily protein MUC18 is involved in transendothelial migration and signal transduction, and is expressed in malignancies including cutaneous melanoma. Recent in vitro studies showed evidence of increased MUC18 protein in some uveal melanoma cell lines with an increased potential for invasion. We assessed seven uveal and three metastasis-derived melanoma cell lines for the expression of MUC18 mRNA and protein by RT-PCR, and immunoblotting and immunocytochemistry, respectively. We also examined the expression and distribution of MUC18 in paraffin sections of primary uveal melanomas (n = 23; 5/23 spindle; 18/23 mixed and epithelioid) and normal eyes (n = 3) using a polyclonal goat anti-human antibody to MUC18 visualized with peroxidase and Vector NovaRED. Distribution and intensity of immunostaining was graded semi-quantitatively (grade 0 to 3) by 2 independent observers. All cell lines expressed MUC18 mRNA and protein ( approximately 130 kDa), and showed punctate cell membrane MUC18 immunostaining. Primary melanomas displayed heterogeneous cell membrane and cytoplasmic MUC18, with moderate to strong immunolabelling (> or =grade 2) in approximately 70% of tumours. Vasculature in tumours and in retina and choroid of all melanoma-affected and normal eyes showed intense MUC18 immunostaining. These observations further suggest a role for MUC18 in uveal melanoma growth; moreover, interactions between MUC18-positive melanoma cells and vasculature may be important for the hematogenous spread of cells during metastases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17786470     DOI: 10.1007/s00428-007-0498-0

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  58 in total

1.  Incidence of ocular melanoma in Australia from 1990 to 1998.

Authors:  Claire M Vajdic; Anne Kricker; Michael Giblin; John McKenzie; Joanne Aitken; Graham G Giles; Bruce K Armstrong
Journal:  Int J Cancer       Date:  2003-05-20       Impact factor: 7.396

Review 2.  The RAS/RAF/MEK/ERK and PI3K/AKT signaling pathways present molecular targets for the effective treatment of advanced melanoma.

Authors:  Friedegund Meier; Birgit Schittek; Silke Busch; Claus Garbe; Keiran Smalley; Kapaettu Satyamoorthy; Gang Li; Meenhard Herlyn
Journal:  Front Biosci       Date:  2005-09-01

Review 3.  Role of AP-2 in tumor growth and metastasis of human melanoma.

Authors:  M Bar-Eli
Journal:  Cancer Metastasis Rev       Date:  1999       Impact factor: 9.264

4.  Expression of CD146 adhesion molecules (MUC18 or MCAM) in the thymic microenvironment.

Authors:  A Seftalioğlu; L Karakoç
Journal:  Acta Histochem       Date:  2000-02       Impact factor: 2.479

5.  Outside-in signaling pathway linked to CD146 engagement in human endothelial cells.

Authors:  F Anfosso; N Bardin; E Vivier; F Sabatier; J Sampol; F Dignat-George
Journal:  J Biol Chem       Date:  2001-01-12       Impact factor: 5.157

6.  Expression profiling reveals that methylation of TIMP3 is involved in uveal melanoma development.

Authors:  Pieter A van der Velden; Wieke Zuidervaart; Monique H M H Hurks; Sandra Pavey; Bruce R Ksander; Elise Krijgsman; Rune R Frants; Cornelis P Tensen; Rein Willemze; Martine J Jager; Nelleke A Gruis
Journal:  Int J Cancer       Date:  2003-09-10       Impact factor: 7.396

7.  MUC18, a melanoma-progression associated molecule, and its potential role in tumor vascularization and hematogenous spread.

Authors:  C Sers; G Riethmüller; J P Johnson
Journal:  Cancer Res       Date:  1994-11-01       Impact factor: 12.701

8.  The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma.

Authors:  J M Bosher; T Williams; H C Hurst
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

Review 9.  Remodeling of the microenvironment by aggressive melanoma tumor cells.

Authors:  Mary J C Hendrix; Elisabeth A Seftor; Dawn A Kirschmann; Vito Quaranta; Richard E B Seftor
Journal:  Ann N Y Acad Sci       Date:  2003-05       Impact factor: 5.691

10.  Molecular determinants of human uveal melanoma invasion and metastasis.

Authors:  Elisabeth A Seftor; Paul S Meltzer; Dawn A Kirschmann; Jacob Pe'er; Andrew J Maniotis; Jeffrey M Trent; Robert Folberg; Mary J C Hendrix
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

View more
  1 in total

1.  Inhibition of CD146 lessens uveal melanoma progression through reducing angiogenesis and vasculogenic mimicry.

Authors:  Ronghan Zhang; Xiaogang Chen; Shengwen Chen; Jiajia Tang; Feng Chen; Yong Lin; Peter Sol Reinach; Xiyun Yan; LiLi Tu; Hongxia Duan; Jia Qu; Qiang Hou
Journal:  Cell Oncol (Dordr)       Date:  2022-06-18       Impact factor: 7.051

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.